Transfection of chimeric anti-CD138 gene enhances natural killer cell activation and killing of multiple myeloma cells-Reference-Cited by-同舟云学术

Transfection of chimeric anti-CD138 gene enhances natural killer cell activation and killing of multiple myeloma cells

Published:2013-12-12 Issue:2 Volume:8 Page:297-310
ISSN:1574-7891
Container-title:Molecular Oncology
language:en
Short-container-title:

Author:

Jiang Hua,Zhang Wenhao,Shang Peipei,Zhang Hui,Fu Weijun,Ye Fei,Zeng Tianmei,Huang Hejing,Zhang Xueguang,Sun Wanping,Man-Yuen Sze Daniel,Yi Qing,Hou Jian

Publisher

Wiley

Subject

Cancer Research,Genetics,Molecular Medicine,General Medicine,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1016/j.molonc.2013.12.001/fullpdf

Reference46 articles.

1. CD107a as a functional marker for the identification of natural killer cell activity;Alter;J. Immunol. Methods,2004

2. Comparative analysis of human NK cell activation induced by NKG2D and natural cytotoxicity receptors;André;Eur. J. Immunol.,2004

3. Infusion of the allogeneic cell line NK-92 in patients with advanced renal cell cancer or melanoma: a phase I trial;Arai;Cytotherapy,2008

4. The phenotype of normal, reactive and malignant plasma cells. Identification of “many and multiple myelomas” and of new targets for myeloma therapy;Bataille;Haematologica,2006

5. Simultaneous targeting of PI3K and mTOR with NVP-BGT226 is highly effective in multiple myeloma;Baumann;Anticancer Drugs,2012

Cited by 223 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Accelerating Accessibility of CAR-T/NK therapies – Are AlloCARs and rapid manufacturing platforms the road ahead in improving access in multiple myeloma?;Seminars in Hematology;2024-09

2. Advancements and Challenges in Cancer Immunotherapy;Advances in Medical Diagnosis, Treatment, and Care;2024-08-28

3. CAR-NK Cell Therapy: A Transformative Approach to Overcoming Oncological Challenges;Biomolecules;2024-08-20

4. Targeting cancer stem cells in multiple myeloma;Trends in Cancer;2024-08

5. Multiple myeloma: signaling pathways and targeted therapy;Molecular Biomedicine;2024-07-04